Skip to main content
. Author manuscript; available in PMC: 2017 Jun 16.
Published in final edited form as: Stem Cells. 2015 Oct 9;34(1):114–123. doi: 10.1002/stem.2190

Figure 3.

Figure 3

Co-immunoprecipitation (IP) assays to detect association of endogenous LSD1, CoREST and Pit-1 with RIP140 antibody in retinoic acid (RA)-treated embryonic stem cells (ESCs) (A) and RA-treated embryoid bodies (B left panel). (B right panel) Co-IP assays to detect association of endogenous CoREST, RIP140, and Pit-1 with LSD1 antibody in RA-treated ESCs. (C): Re-ChIP detection of RIP140-LSD1 and RIP140-Pit-1 complex on Pax6 P1 in ESC treated with RA (3 days).